Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology

Academic Article


  • This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastatic disease. For example, new recommendations were added for atezolizumab, ceritinib, osimertinib, and pembrolizumab for the 2017 updates.
  • Digital Object Identifier (doi)

    Author List

  • Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman J; Chirieac LR; D'Amico TA; Decamp MM; Dilling TJ; Dobelbower M
  • Start Page

  • 504
  • End Page

  • 535
  • Volume

  • 15
  • Issue

  • 4